Fresenius raises 2025 revenue guidance
Aug 6 (Reuters) - German healthcare group Fresenius FREG.DE raised its revenue guidance for 2025 on Wednesday, citing consistent growth seen in the first half of the year. The Hessian-based company now targets 5-7% organic revenue growth, after previously guiding for a range of 4-6%. (Reporting by Tristan Veyet in Gdansk, editing by Milla Nissi-Prussak) ((Tristan.Chabba@thomsonreuters.com;))
Recent news on Fresenius SE & Co. KGaA
See all newsFresenius lifts 2026 expectations after strong Q3 (updated)
Healthcare firm Fresenius Q3 revenue rises on Kabi growth; lifts outlook
Brief: Fresenius Sees FY26 EBIT Margin Above 11.5%
Brief: Fresenius SE Q3 Revenue EUR 5,803 Million
Fresenius signs biosimilars pipeline agreement with WuXi Biologics (updated)